Literature DB >> 24906150

Hippo pathway activity influences liver cell fate.

Dean Yimlamai1, Constantina Christodoulou2, Giorgio G Galli2, Kilangsungla Yanger3, Brian Pepe-Mooney2, Basanta Gurung2, Kriti Shrestha4, Patrick Cahan4, Ben Z Stanger5, Fernando D Camargo6.   

Abstract

The Hippo-signaling pathway is an important regulator of cellular proliferation and organ size. However, little is known about the role of this cascade in the control of cell fate. Employing a combination of lineage tracing, clonal analysis, and organoid culture approaches, we demonstrate that Hippo pathway activity is essential for the maintenance of the differentiated hepatocyte state. Remarkably, acute inactivation of Hippo pathway signaling in vivo is sufficient to dedifferentiate, at very high efficiencies, adult hepatocytes into cells bearing progenitor characteristics. These hepatocyte-derived progenitor cells demonstrate self-renewal and engraftment capacity at the single-cell level. We also identify the NOTCH-signaling pathway as a functional important effector downstream of the Hippo transducer YAP. Our findings uncover a potent role for Hippo/YAP signaling in controlling liver cell fate and reveal an unprecedented level of phenotypic plasticity in mature hepatocytes, which has implications for the understanding and manipulation of liver regeneration.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24906150      PMCID: PMC4136468          DOI: 10.1016/j.cell.2014.03.060

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  337 in total

1.  Hippo signaling is required for Notch-dependent smooth muscle differentiation of neural crest.

Authors:  Lauren J Manderfield; Haig Aghajanian; Kurt A Engleka; Lillian Y Lim; Feiyan Liu; Rajan Jain; Li Li; Eric N Olson; Jonathan A Epstein
Journal:  Development       Date:  2015-08-07       Impact factor: 6.868

Review 2.  Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine.

Authors:  Anwesha Dey; Xaralabos Varelas; Kun-Liang Guan
Journal:  Nat Rev Drug Discov       Date:  2020-06-17       Impact factor: 84.694

Review 3.  Recent Advances of the Hippo/YAP Signaling Pathway in Brain Development and Glioma.

Authors:  Taohui Ouyang; Wei Meng; Meihua Li; Tao Hong; Na Zhang
Journal:  Cell Mol Neurobiol       Date:  2019-11-25       Impact factor: 5.046

4.  The Hippo Effector Transcriptional Coactivator with PDZ-Binding Motif Cooperates with Oncogenic β-Catenin to Induce Hepatoblastoma Development in Mice and Humans.

Authors:  Shu Zhang; Jie Zhang; Katja Evert; Xiaolei Li; Pin Liu; Andras Kiss; Zsuzsa Schaff; Cindy Ament; Yi Zhang; Monica Serra; Matthias Evert; Nianyong Chen; Feng Xu; Xin Chen; Junyan Tao; Diego F Calvisi; Antonio Cigliano
Journal:  Am J Pathol       Date:  2020-04-10       Impact factor: 4.307

5.  Colon cancer stem cells: Potential target for the treatment of colorectal cancer.

Authors:  Riya Gupta; Lokesh Kumar Bhatt; Thomas P Johnston; Kedar S Prabhavalkar
Journal:  Cancer Biol Ther       Date:  2019-05-03       Impact factor: 4.742

6.  Liver regeneration requires Yap1-TGFβ-dependent epithelial-mesenchymal transition in hepatocytes.

Authors:  Seh-Hoon Oh; Marzena Swiderska-Syn; Mark L Jewell; Richard T Premont; Anna Mae Diehl
Journal:  J Hepatol       Date:  2018-05-23       Impact factor: 25.083

7.  HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis.

Authors:  Celine Hernandez; Peter Huebener; Jean-Philippe Pradere; Daniel J Antoine; Richard A Friedman; Robert F Schwabe
Journal:  J Clin Invest       Date:  2018-05-07       Impact factor: 14.808

8.  Epigenetic restriction of Hippo signaling by MORC2 underlies stemness of hepatocellular carcinoma cells.

Authors:  Tao Wang; Zhong-Yi Qin; Liang-Zhi Wen; Yan Guo; Qin Liu; Zeng-Jie Lei; Wei Pan; Kai-Jun Liu; Xing-Wei Wang; Shu-Jie Lai; Wen-Jing Sun; Yan-Ling Wei; Lei Liu; Ling Guo; Yu-Qin Chen; Jun Wang; Hua-Liang Xiao; Xiu-Wu Bian; Dong-Feng Chen; Bin Wang
Journal:  Cell Death Differ       Date:  2018-03-19       Impact factor: 15.828

Review 9.  APSA Awardee Submission: Tumor/cancer stem cell marker doublecortin-like kinase 1 in liver diseases.

Authors:  Charles B Nguyen; Courtney W Houchen; Naushad Ali
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-04

Review 10.  Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational Significances.

Authors:  Keisaku Sato; Marco Marzioni; Fanyin Meng; Heather Francis; Shannon Glaser; Gianfranco Alpini
Journal:  Hepatology       Date:  2018-12-27       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.